-
Needham & Company LLC Reaffirms "Buy" Rating for Cartesian Therapeutics (NASDAQ:RNAC)
Source: Buzz FX / 14 Mar 2025 13:16:17 America/Chicago
Needham & Company LLC Reaffirms "Buy" Rating for Cartesian Therapeutics (NASDAQ:RNAC) Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Cartesian Therapeutics ( NASDAQ:RNAC - Get Free Report ) 's stock had its
Read more...